The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic mutation profiling (GMP) and clinical outcome of patients treated with buparlisib (PI3K inhibitor) in the “Signature” program.
 
Sarina Anne Piha-Paul
Research Funding - Biomarin; GlaxoSmithKline; Helix BioPharma; Merck; Novartis; Puma Biotechnology
 
James A. Knost
No Relationships to Disclose
 
Fadi S. Braiteh
Employment - US Oncology (I)
Stock and Other Ownership Interests - Celgene; Insys Therapeutics
Honoraria - Amgen; BIND Therapeutics; Caris Life Sciences; Dendreon; Foundation Medicine; Incyte; Insys Therapeutics; MolecularHealth; Novartis; Pfizer; Saladax Biomedical; Sanofi
Consulting or Advisory Role - Amgen; BIND Therapeutics; Caris Life Sciences; Dendreon; Foundation Medicine; Incyte; Insys Therapeutics; MolecularHealth; Novartis; Pfizer; Saladax Biomedical; Sanofi
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Caris Life Sciences; Celgene; Genomic Health; Incyte; Insys Therapeutics; Myriad Pharmaceuticals; Novartis; Pfizer; Sanofi
Research Funding - Abbvie (Inst); Active Biotech (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BIND Therapeutics (Inst); Biomarin (Inst); bioTheranostics (Inst); BN ImmunoTherapeutics (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); Celgene (Inst); Cell Therapeutics (Inst); Daiichi Sankyo (Inst); Dendreon (Inst); Endocyte (Inst); Exelixis (Inst); Foundation Medicine (Inst); Genomic Health (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); HERON (Inst); ImClone Systems (Inst); Incyte (Inst); Insys Therapeutics (Inst); Janssen (Inst); Lilly (Inst); MEI Pharma (Inst); Merrimack (Inst); Millennium (Inst); MolecularHealth (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Plexxikon (Inst); PSMA Development Company (Inst); Roche/Genentech (Inst); Saladax Biomedical (Inst); Sanofi (Inst); Seagen (Inst); Viamet Pharmaceuticals (Inst)
 
J. Thaddeus Beck
Consulting or Advisory Role - Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst)
 
Daniel Lewis Spitz
No Relationships to Disclose
 
Steven W. Papish
Speakers' Bureau - Genentech; Genomic Health; Novartis
 
Beth A. Hellerstedt
No Relationships to Disclose
 
Petros Nikolinakos
Consulting or Advisory Role - Boehringer Ingelheim; Exelixis; Lilly
Speakers' Bureau - Boehringer Ingelheim
 
Matthew Hiram Taylor
Consulting or Advisory Role - Eisai; Onyx; PDX Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Eisai (Inst); Merck KGaA (Inst); Novartis (Inst)
 
Sant P. Chawla
Honoraria - Amgen; Cytrax; Johnson & Johnson; PharmaMar; Threshold Pharmaceuticals
Consulting or Advisory Role - Amgen; Cytrax; Johnson & Johnson; PharmaMar; Threshold Pharmaceuticals
Research Funding - Amgen; Cytrax; Johnson & Johnson; PharmaMar; Threshold Pharmaceuticals
Travel, Accommodations, Expenses - Amgen; Cytrax; PharmaMar; Threshold Pharmaceuticals
 
Lee Steven Schwartzberg
Leadership - Vector Oncology
Consulting or Advisory Role - Amgen; Eisai; Genentech; Teva
Speakers' Bureau - Eisai; Genentech; Novartis
Research Funding - Eisai
 
David A. Smith
Employment - Compass Oncology; McKesson
Leadership - Compass Oncology; McKesson
Research Funding - McKesson
Travel, Accommodations, Expenses - McKesson
 
Sebastian Szpakowski
Employment - Novartis (I)
Stock and Other Ownership Interests - Alexion Pharmaceuticals (I)
 
Lening Zhang
Consulting or Advisory Role - Novartis
 
Theresa White
Employment - Novartis (I)
 
Claudia Lebedinsky
Employment - Novartis